DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Companies / S•••••• P••••• I•••
S•••••• P••••• I•••
Series AShreveport, LABiotechnology
Facts
Financing history
2 rounds
- Feb 18, 2026Series A · $18.0M (disclosed)Fact Press release · “••• Locked”
- Jan 20, 2026Form D equity offering · $16.4M (form d sold) · 29 investorsFact Form D · “••• Locked”
Investors on record
0 edges
No named investor yet.
People
1 officers, 1 directors
- S•••• K•••••••• C••••• Executive Officer sec.gov
- R•••• K•••••••• Director Fact
Timeline
2
- Feb 18, 2026••• LockedRound announced Fact Press release
- Feb 3, 2026••• LockedForm D filed Fact Form D
Evidence
16 observations
Every observation on this company
- Entity type: Corporation Feb 3, 2026 Fact Form D
- Form D industry group: Biotechnology Feb 3, 2026 Fact Form D
- Amendment: false Feb 3, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Feb 3, 2026 Fact Form D
- Incorporated: withinFiveYears Feb 3, 2026 Fact Form D
- Jurisdiction: Delaware Feb 3, 2026 Fact Form D
- Amount sold (Form D): $16.4M Feb 3, 2026 Fact Form D
- Offering amount (Form D): $22.2M Feb 3, 2026 Fact Form D
- Exemptions: 06b Feb 3, 2026 Fact Form D
- First sale: 2026-01-20 Feb 3, 2026 Fact Form D
- Investors (Form D): 29 Feb 3, 2026 Fact Form D
- Minimum investment (Form D): 50,000 Feb 3, 2026 Fact Form D
- Securities offered: equity Feb 3, 2026 Fact Form D
- Office address: ••• Locked Feb 3, 2026 Fact Form D
- Round announced: Series A $18,000,000 Feb 18, 2026 Fact Press release
- Year of incorporation: 2025 Feb 3, 2026 Fact Form D